Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes mellitus. Prattichizzo F, Giuliani A, Sabbatinelli J, Matacchione G, et al. Diabetes Obes Metab 2020 May 11. doi: 10.1111/dom.14081.

Read + Share

Amedeo Smart

Independent Medical Education

Prattichizzo F, Giuliani A, Sabbatinelli J, Matacchione G, et al. Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes mellitus. Diabetes Obes Metab 2020 May 11. doi: 10.1111/dom.14081.
PMID: 32394604